This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Medical Properties (MPW) Stock Moves -0.8%: What You Should Know
by Zacks Equity Research
In the most recent trading session, Medical Properties (MPW) closed at $3.73, indicating a -0.8% shift from the previous trading day.
Is Most-Watched Stock Medical Properties Trust, Inc. (MPW) Worth Betting on Now?
by Zacks Equity Research
Medical Properties (MPW) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Medical Properties (MPW) Registers a Bigger Fall Than the Market: Important Facts to Note
by Zacks Equity Research
In the latest trading session, Medical Properties (MPW) closed at $3.76, marking a -0.27% move from the previous day.
Medical Properties Trust, Inc. (MPW) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Medical Properties (MPW) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Medical Properties Trust, Inc. (MPW) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Medical Properties (MPW) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Investors Heavily Search Medical Properties Trust, Inc. (MPW): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Medical Properties (MPW). This makes it worthwhile to examine what the stock has in store.
Medical Properties Trust, Inc. (MPW) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Medical Properties (MPW). This makes it worthwhile to examine what the stock has in store.
Medical Properties (MPW) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Medical Properties (MPW) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Medical Properties (MPW) Q3 FFO and Revenues Lag Estimates
by Zacks Equity Research
Medical Properties (MPW) delivered FFO and revenue surprises of -20% and 6.37%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Tesla and Nike have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Tesla and Nike are part of the Zacks Bull and Bear of the Day article.
Plymouth Industrial (PLYM) Q3 FFO Lag Estimates
by Zacks Equity Research
Plymouth Industrial (PLYM) delivered FFO and revenue surprises of -8.33% and 4.30%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Buy, Sell or Hold Medical Properties? Key Tips Ahead of Q3 Earnings
by Rohit Vasant Fatarpekar
MPW's Q3 earnings are likely to have been hurt by exposure to troubled operators and high interest expenses.
National Health Investors (NHI) Q3 FFO Miss Estimates
by Zacks Equity Research
National Health Investors (NHI) delivered FFO and revenue surprises of -3.74% and 2.78%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Medical Properties (MPW) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Get a deeper insight into the potential performance of Medical Properties (MPW) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Medical Properties (MPW) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
Medical Properties (MPW) closed at $4.71 in the latest trading session, marking a +1.07% move from the prior day.
Medical Properties Stock Down 3% in 3 Months: Time to Buy or Red Flag?
by Rohit Vasant Fatarpekar
Despite strong healthcare industry fundamentals, investors seem pessimistic about MPW due to stock sale news, dividend pay cut and southward revision of FFO estimates.
Medical Properties Trust, Inc. (MPW) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Medical Properties (MPW). This makes it worthwhile to examine what the stock has in store.
Medical Properties (MPW) Laps the Stock Market: Here's Why
by Zacks Equity Research
Medical Properties (MPW) reachead $4.73 at the closing of the latest trading day, reflecting a +0.85% change compared to its last close.
Medical Properties Trust, Inc. (MPW) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Medical Properties (MPW) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's Why Medical Properties (MPW) Gained But Lagged the Market Today
by Zacks Equity Research
In the closing of the recent trading day, Medical Properties (MPW) stood at $5.72, denoting a +0.7% change from the preceding trading day.
Medical Properties Trust, Inc. (MPW) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Medical Properties (MPW) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Medical Properties (MPW) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
The latest trading day saw Medical Properties (MPW) settling at $5.95, representing a +0.85% change from its previous close.
Medical Properties (MPW) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the closing of the recent trading day, Medical Properties (MPW) stood at $5.90, denoting a -0.51% change from the preceding trading day.
MPW Stock Surges 33.9% in a Month: Should You Buy Now or Wait?
by Zacks Equity Research
Medical Properties rides on interest rate cut, control over its real estate from Steward and balance-sheet strengthening efforts despite operator concentration.
Investors Heavily Search Medical Properties Trust, Inc. (MPW): Here is What You Need to Know
by Zacks Equity Research
Medical Properties (MPW) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.